PCR249 Advancing Equity, Diversity, Inclusion, and Belonging in Patient Centered Drug Development with Patient Preference Research

Abstract

Regulators and pharmaceutical and medical device manufacturers acknowledge the role patient-preference research can play in patient-focused drug development (PFDD). The growing recognition of the value of equity, diversity, inclusion, and belonging (EDIB) initiatives has challenged stakeholders to identify opportunities to promote diverse healthcare perspectives from underserved populations. Applying EDIB principles to the collection, interpretation, and use of patient preference information (PPI) in PFDD can support more inclusive and equitable health outcomes. We present specific examples of how PPI can advance EDIB in PFDD, as well as challenges.